Strs Ohio Amylyx Pharmaceuticals, Inc. Transaction History

Strs Ohio

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.71 - $19.57 $2,710 - $19,570	-1,000 Reduced 5.71%	16,500 $46,000
Q4 2023 Jan 30, 2024	BUY	$12.07 - $18.46 $211,225 - $323,050	17,500 New	17,500 $257,000
Q1 2023 Aug 02, 2023	BUY	$27.71 - $40.93 $340,833 - $503,439	12,300 New	12,300 $360,000
Q1 2023 Apr 27, 2023	BUY	$27.71 - $40.93 $216,138 - $319,254	7,800 Added 173.33%	12,300 $360,000
Q4 2022 Jan 26, 2023	BUY	$29.75 - $39.26 $98,175 - $129,558	3,300 Added 275.0%	4,500 $166,000
Q2 2022 Jul 25, 2022	SELL	$6.85 - $19.93 $7,535 - $21,923	-1,100 Reduced 47.83%	1,200 $23,000
Q1 2022 Apr 21, 2022	BUY	$12.85 - $32.9 $29,555 - $75,670	2,300 New	2,300 $29,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $308M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.